Paul Peter Tak
Paul Peter Tak is a business leader, academic, entrepreneur and clinician who has over 30 years’ experience in medicine as a prominent expert in Immunology, Internal Medicine, and Rheumatology. Paul Peter is currently the President, CEO, and Board Director of Candel Therapeutics, the Co-Founder and Board Director of Sitryx Therapeutics, and Board Director of Levicept and Citryll.
Alongside his industry career, Paul Peter has dedicated much of his life to academia and advancing our understanding in medicine. He has served as Professor of Medicine at the University of Amsterdam and holds numerous honours for his service to medicine, with a special focus on Immunology and Rheumatology.
Builders🧱 w/ Paul Peter Tak @CandelTx
Uncover @CandelTx's genesis with @paulpetertak as we explore their viral immunotherapies reshaping precision medicine. Dive into Paul's journey as an immunology pioneer, unveiling @CandelTx's future!
Tune in: https://buff.ly/4aNNqf8
@CandelTx @paulpetertak 🌟 Dive deep into the world of viral immunotherapy and autoimmune diseases with @paulpetertak on our podcast! Discover how innovative approaches like viral immunotherapies and bioelectronics are transforming the landscape of disease treatment and prevention.
Looking forward to seeing many friends and colleagues at ABI2024 in Cambridge!
Accelerating Bio-Innovation Conference | Royalty Pharma
